EMA’s PRAC Revises Methods for Measuring Pharmacovigilance Impacts

Drug Industry Daily
A A
The European Medicines Agency’s pharmacovigilance committee revised its methods for measuring the health outcomes of its major regulatory interventions, aiming to improve industry safety monitoring practices and find out which activities have been the most successful.

To View This Article:

Login

Subscribe To Drug Industry Daily